Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeActive Not Recruiting
Sponsor: Corcept Therapeutics
Cushing Syndrome
United States, Austria, Canada, Germany, Israel +5 more
Sponsor: Zealand Pharma
Healthy Participants Study · Overweight and Obese Adults · First in Man Study to Evaluate Initial Safety
Germany
Sponsor: Novo Nordisk A/S
Sickle Cell Disease · Thalassemia
United States, Canada, Egypt, France, Germany +12 more
Sponsor: Viridian Therapeutics, Inc.
Thyroid Eye Disease
United States, Australia, France, Germany, Poland +2 more
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsActive Not Recruiting
Sponsor: Novo Nordisk A/S
Haemophilia A Without Inhibitors · Haemophilia B Without Inhibitors
United States, Algeria, Australia, Bosnia and Herzegovina, Bulgaria +28 more
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
Germany, Switzerland
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
- A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus InfectionNot Yet Recruiting
Sponsor: Assembly Biosciences
Chronic Hepatitis D Infection
France, Georgia, Germany, Italy, Moldova +6 more
Sponsor: W.L.Gore & Associates
Chronic Kidney Diseases · End Stage Renal Disease on Dialysis
Germany, Italy, United Kingdom
Sponsor: VDyne, Inc.
Tricuspid Regurgitation · Tricuspid Valve Disease · Tricuspid Valvular Disorders
Australia, Austria, Belgium, Czechia, Denmark +6 more
- Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNActive Not Recruiting
Sponsor: AstraZeneca
Neurofibromatosis Type 1
United States, Germany, Italy, Japan, Netherlands +2 more
Sponsor: Merck Sharp & Dohme LLC
Essential Thrombocythemia
United States, Argentina, Australia, Belgium, Canada +19 more
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Brazil, Bulgaria, Canada +9 more
- Auricular Acupressure for Perioperative Anxiety and Pain in Therapeutic Breast Surgery (ROSA)Recruiting
Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Breast Cancer Females
Germany
- OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerActive Not Recruiting
Sponsor: Olema Pharmaceuticals, Inc.
Breast Cancer · Advanced Breast Cancer · Metastatic Breast Cancer · ER Positive Breast Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
- Observational Study Protocol: LIVER-RRecruiting
Sponsor: AstraZeneca
Hepatobiliary Cancers
United States, Australia, Austria, Belgium, Brazil +17 more
- A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesActive Not Recruiting
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 1
Germany
Sponsor: Rein Therapeutics
Idiopathic Pulmonary Fibrosis (IPF)
United States, Australia, Germany, Poland, United Kingdom
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Belgium, Canada, Germany, Israel +7 more
- A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruiting
Sponsor: Apollo Therapeutics Ltd
Atopic Dermatitis · Atopic · Dermatitis · Dermatitis, Atopic
United States, Bulgaria, Canada, Czechia, Germany +3 more
Sponsor: University of Leipzig
Gastrectomy
Germany
Sponsor: BioNTech SE
HIV -1 Infection
United States, Germany
- A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative NeoplasmsActive Not Recruiting
Sponsor: Incyte Corporation
Myeloproliferative Neoplasms
United States, Canada, France, Germany, Italy +3 more
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive Not Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer
United States, Argentina, Australia, Austria, Belgium +33 more
Sponsor: MoonLake Immunotherapeutics AG
Hidradenitis Suppurativa
United States, Bulgaria, Canada, Germany, Hungary +5 more